NovoCure (NVCR) Other Non-Current Assets (2014 - 2026)
NovoCure recorded quarterly Other Non-Current Assets of $11.2 million in Q1 2026, up 5.7% quarter-over-quarter from $10.6 million in Q4 2025, and down 22.67% year-over-year from $14.5 million in Q1 2025.
NovoCure's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 22.67% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (down 22.67% YoY), while the FY2025 annual figure was $10.6 million, down 27.51% from the prior year.
- Other Non-Current Assets came in at $11.2 million for Q1 2026 at NovoCure, up from $10.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $15.6 million in Q2 2025 to a low of $10.6 million in Q4 2025.
- A 5-year average of $12.6 million and a median of $12.2 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets jumped 33.71% in 2023 and declined 27.51% in 2025, its largest moves.
- NovoCure's Other Non-Current Assets stood at $11.2 million in 2022, then grew by 25.63% to $14.0 million in 2023, then advanced by 4.25% to $14.6 million in 2024, then dropped by 27.51% to $10.6 million in 2025, then rose by 5.7% to $11.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $11.2 million, $10.6 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 10.60 Mn |
| Sep 30, 2025 | 12.41 Mn |
| Jun 30, 2025 | 15.56 Mn |
| Mar 31, 2025 | 14.48 Mn |
| Dec 31, 2024 | 14.62 Mn |
| Sep 30, 2024 | 12.22 Mn |
| Jun 30, 2024 | 12.06 Mn |
| Mar 31, 2024 | 14.90 Mn |
| Dec 31, 2023 | 14.02 Mn |
| Sep 30, 2023 | 12.42 Mn |
| Jun 30, 2023 | 14.57 Mn |
| Mar 31, 2023 | 11.15 Mn |
| Dec 31, 2022 | 11.16 Mn |
| Sep 30, 2022 | 10.71 Mn |
| Jun 30, 2022 | 10.90 Mn |
| Mar 31, 2022 | 11.83 Mn |
| Dec 31, 2021 | 12.09 Mn |
| Sep 30, 2021 | 10.74 Mn |
| Jun 30, 2021 | 10.63 Mn |
| Mar 31, 2021 | 10.79 Mn |
| Dec 31, 2020 | 10.91 Mn |
| Sep 30, 2020 | 11.04 Mn |
| Jun 30, 2020 | 4.86 Mn |
| Mar 31, 2020 | 4.82 Mn |
| Dec 31, 2019 | 4.90 Mn |
| Sep 30, 2019 | 5.72 Mn |
| Jun 30, 2019 | 5.68 Mn |
| Mar 31, 2019 | 4.98 Mn |
| Dec 31, 2018 | 3.06 Mn |
| Sep 30, 2018 | 1.15 Mn |
| Jun 30, 2018 | 2.88 Mn |
| Mar 31, 2018 | 113,000.00 |
| Dec 31, 2017 | 1.99 Mn |
| Sep 30, 2017 | 104,000.00 |
| Jun 30, 2017 | 1.77 Mn |
| Mar 31, 2017 | 1.04 Mn |
| Dec 31, 2016 | 1.50 Mn |
| Sep 30, 2016 | 807,000.00 |
| Jun 30, 2016 | 1.08 Mn |
| Mar 31, 2016 | 992,000.00 |
| Dec 31, 2015 | 79,000.00 |
| Sep 30, 2015 | 1.71 Mn |
| Dec 31, 2014 | 227,000.00 |